Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Franchini, M
Right arrow Articles by Brazzarola, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Franchini, M
Right arrow Articles by Brazzarola, P
Haematologica, Vol 89, Issue 11, 1341-1346
Copyright © 2004 by Ferrata Storti Foundation


Journal Article

High prevalence of acquired von Willebrand's syndrome in patients with thyroid diseases undergoing thyroid surgery

M Franchini, C Zugni, D Veneri, G Gandini, G Lippi, F Manzato, and P Brazzarola

Servizio di Immunoematologia e Trasfusione, Centro Emofilia, Azienda Ospedaliera di Verona, Verona, Italy. massimo.franchini@mail.azosp.vr.it

BACKGROUND AND OBJECTIVES: Various coagulation abnormalities occur in patients with thyroid diseases. These abnormalities range from subclinical laboratory findings to hemorrhage or thromboembolism. However, the prevalence of hemostatic abnormalities in patients with thyroid diseases is still unclear. DESIGN AND METHODS: Between January 1999 and December 2003, 1342 consecutive patients with various thyroid diseases who were candidates for thyroid surgery underwent preoperative screening of hemostatic parameters including prothrombin time, activated partial thromboplastin time and platelet-related hemostasis with the PFA-100 platelet-function analyzer. RESULTS: Thirty-nine patients (2.9%) had abnormalities of the coagulation screening tests. Of these, 35 patients had von Willebrand's disease (type 1 in 33 cases and type 2A in 2 cases), 2 patients had decreased platelet aggregability, and 2 patients had coagulation factor XI deficiency. As all patients with coagulation abnormalities responded to subcutaneous desmopressin injection (0.3 microg/Kg BW), this drug was successfully used as surgical prophylaxis. INTERPRETATION AND CONCLUSIONS: Up to 3% of patients with thyroid diseases undergoing thyroid surgery have coagulation abnormalities, in most cases resembling von Willebrand's disease. Coagulation screening tests are needed in order to identify those patients at increased risk of bleeding.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. Homoncik, A. Gessl, A. Ferlitsch, B. Jilma, and H. Vierhapper
Altered Platelet Plug Formation in Hyperthyroidism and Hypothyroidism
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3006 - 3012.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Squizzato, E. Romualdi, H. R. Buller, and V. E. A. Gerdes
Thyroid Dysfunction and Effects on Coagulation and Fibrinolysis: A Systematic Review
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2415 - 2420.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2004 by the Ferrata Storti Foundation.